Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

1.

Neurotuberculosis immune reconstitution inflammatory syndrome in the setting of HIV infection: A case report and review of literature.

Jaganmohan D, Chakkalakkoombil SV, Beena AA, Krishnan N.

Indian J Radiol Imaging. 2016 Oct-Dec;26(4):446-450. doi: 10.4103/0971-3026.195782.

2.

Current trends and intricacies in the management of HIV-associated pulmonary tuberculosis.

Gopalan N, Chandrasekaran P, Swaminathan S, Tripathy S.

AIDS Res Ther. 2016 Sep 26;13:34. eCollection 2016 Sep 26. Review.

3.

Prolonged tuberculosis-associated immune reconstitution inflammatory syndrome: characteristics and risk factors.

Bana TM, Lesosky M, Pepper DJ, van der Plas H, Schutz C, Goliath R, Morroni C, Mendelson M, Maartens G, Wilkinson RJ, Meintjes G.

BMC Infect Dis. 2016 Sep 27;16(1):518.

4.

Role of LTA4H Polymorphism in Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome Occurrence and Clinical Severity in Patients Infected with HIV.

Narendran G, Kavitha D, Karunaianantham R, Gil-Santana L, Almeida-Junior JL, Reddy SD, Kumar MM, Hemalatha H, Jayanthi NN, Ravichandran N, Krishnaraja R, Prabhakar A, Manoharan T, Nithyananthan L, Arjunan G, Natrajan M, Swaminathan S, Andrade BB.

PLoS One. 2016 Sep 19;11(9):e0163298. doi: 10.1371/journal.pone.0163298. eCollection 2016 Sep 19.

5.

Determinants of treatment-related paradoxical reactions during anti-tuberculosis therapy: a case control study.

Brown CS, Smith CJ, Breen RA, Ormerod LP, Mittal R, Fisk M, Milburn HJ, Price NM, Bothamley GH, Lipman MC.

BMC Infect Dis. 2016 Sep 6;16:479. doi: 10.1186/s12879-016-1816-4.

6.

Preventing Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome in High-Risk Patients: Protocol of a Randomized Placebo-Controlled Trial of Prednisone (PredART Trial).

Stek C, Schutz C, Blumenthal L, Thienemann F, Buyze J, Nöstlinger C, Ravinetto R, Wouters E, Colebunders R, Maartens G, Wilkinson RJ, Lynen L, Meintjes G.

JMIR Res Protoc. 2016 Aug 29;5(3):e173. doi: 10.2196/resprot.6046.

7.

Paradoxical reaction in tuberculous meningitis: presentation, predictors and impact on prognosis.

Singh AK, Malhotra HS, Garg RK, Jain A, Kumar N, Kohli N, Verma R, Sharma PK.

BMC Infect Dis. 2016 Jun 21;16:306. doi: 10.1186/s12879-016-1625-9.

8.

Integrated therapy for HIV and tuberculosis.

Manosuthi W, Wiboonchutikul S, Sungkanuparph S.

AIDS Res Ther. 2016 May 12;13:22. doi: 10.1186/s12981-016-0106-y. eCollection 2016 May 12. Review.

9.

Matrix Metalloproteinases in Tuberculosis-Immune Reconstitution Inflammatory Syndrome and Impaired Lung Function Among Advanced HIV/TB Co-infected Patients Initiating Antiretroviral Therapy.

Ravimohan S, Tamuhla N, Kung SJ, Nfanyana K, Steenhoff AP, Gross R, Weissman D, Bisson GP.

EBioMedicine. 2015 Nov 25;3:100-7. doi: 10.1016/j.ebiom.2015.11.040. eCollection 2015 Nov 25.

10.

In Vivo Molecular Dissection of the Effects of HIV-1 in Active Tuberculosis.

Bell LC, Pollara G, Pascoe M, Tomlinson GS, Lehloenya RJ, Roe J, Meldau R, Miller RF, Ramsay A, Chain BM, Dheda K, Noursadeghi M.

PLoS Pathog. 2016 Mar 17;12(3):e1005469. doi: 10.1371/journal.ppat.1005469. eCollection 2016 Mar 17.

11.

Biomarkers for Identifying Risk of Immune Reconstitution Inflammatory Syndrome.

Wilkinson KA, Walker N.

EBioMedicine. 2016 Feb 6;4:9-10. doi: 10.1016/j.ebiom.2016.02.013. eCollection 2016 Feb 6. No abstract available.

12.

Towards a scalable HIV cure research agenda: the role of co-infections.

Sereti I, Folkers GK, Meintjes G, Boulware DR.

J Virus Erad. 2015;1(4):269-271. Epub 2015 Sep 24.

13.

Fighting the Monster: Applying the Host Damage Framework to Human Central Nervous System Infections.

Panackal AA, Williamson KC, van de Beek D, Boulware DR, Williamson PR.

MBio. 2016 Jan 26;7(1):e01906-15. doi: 10.1128/mBio.01906-15. Review.

14.

HIV infection and immune activation: the role of coinfections.

Boulougoura A, Sereti I.

Curr Opin HIV AIDS. 2016 Mar;11(2):191-200. doi: 10.1097/COH.0000000000000241. Review.

15.

Robust Reconstitution of Tuberculosis-Specific Polyfunctional CD4+ T-Cell Responses and Rising Systemic Interleukin 6 in Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome.

Ravimohan S, Tamuhla N, Nfanyana K, Steenhoff AP, Letlhogile R, Frank I, MacGregor RR, Gross R, Weissman D, Bisson GP.

Clin Infect Dis. 2016 Mar 15;62(6):795-803. doi: 10.1093/cid/civ978. Epub 2015 Nov 26.

16.

Time to ART Initiation among Patients Treated for Rifampicin-Resistant Tuberculosis in Khayelitsha, South Africa: Impact on Mortality and Treatment Success.

Daniels JF, Khogali M, Mohr E, Cox V, Moyo S, Edginton M, Hinderaker SG, Meintjes G, Hughes J, De Azevedo V, van Cutsem G, Cox HS.

PLoS One. 2015 Nov 10;10(11):e0142873. doi: 10.1371/journal.pone.0142873. eCollection 2015 Nov 10.

17.

HIV-1 tuberculosis-associated immune reconstitution inflammatory syndrome.

Lai RP, Meintjes G, Wilkinson RJ.

Semin Immunopathol. 2016 Mar;38(2):185-98. doi: 10.1007/s00281-015-0532-2. Epub 2015 Sep 30. Review.

18.

HIV-tuberculosis-associated immune reconstitution inflammatory syndrome is characterized by Toll-like receptor and inflammasome signalling.

Lai RP, Meintjes G, Wilkinson KA, Graham CM, Marais S, Van der Plas H, Deffur A, Schutz C, Bloom C, Munagala I, Anguiano E, Goliath R, Maartens G, Banchereau J, Chaussabel D, O'Garra A, Wilkinson RJ.

Nat Commun. 2015 Sep 24;6:8451. doi: 10.1038/ncomms9451.

19.

Screening Optimization of Latent Tuberculosis Infection in Rheumatoid Arthritis Patients.

Mehta B, Zapantis E, Petryna O, Efthimiou P.

Arthritis. 2015;2015:569620. doi: 10.1155/2015/569620. Epub 2015 Jul 29.

20.

Immune reconstitution inflammatory syndrome.

Barthwal MS, Garg Y, Bhattacharya D, Katoch CD, Rajput AK, Marwah V.

Med J Armed Forces India. 2015 Jul;71(Suppl 1):S251-3. doi: 10.1016/j.mjafi.2014.07.003. Epub 2014 Oct 8. No abstract available.

Supplemental Content

Support Center